Oruka Therapeutics Announces $200 Million Private Placement
MENLO PARK, Calif., Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- Oruka Therapeutics, Inc. ( "Oruka" or the "Company" ) ( Nasdaq: ORKA ) , a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, today ...
Ticker |
Sentiment |
Impact |
JHG
|
Neutral
|
3 %
|
BX
|
Neutral
|
3 %
|